N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
Details for Australian Patent Application No. 2003240677 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 0206783 03.06.02 FR
12 February 2004 Application Open to Public Inspection
Published as AU-B-2003240677
22 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
17 July 2008 Application Accepted
Published as AU-B-2003240677
13 November 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003240678-HYDRAULIC TENSIONING DEVICE
2003240676-AN APPARATUS AND METHOD FOR RESOURCE ALLOCATION IN A COMMUNICATION SYSTEM
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser